MedPath

Care Transitions in Renal Disease Patients

Conditions
Renal Disease
Registration Number
NCT01842776
Lead Sponsor
Fresenius Medical Care North America
Brief Summary

The goal of this pilot is to reduce the 30-day hospital readmission rate for dialysis patients. It is a quality improvement project that consistent of 4 "tracks." Tracks 1 \& 2: Implement use of checklists of activities for staff to complete when patients are admitted to the hospital, and post-hospitalization with emphasis on fluid assessment, nutrition management, patient coaching, and communication between institutions. Track 3: Work with physicians to develop process to individualize post-hospitalization dialysis orders and improve medication reconciliation. Track 4: Use a renal Care Transitions Case Manager to follow patients in the hospital and 30 days post-hospitalization to facilitate care and patient coaching.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
3300
Inclusion Criteria
  • Chronic hemodialysis patients
  • All patients admitted to the hospital during the study period
Exclusion Criteria
  • Patients <18 years old

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
30-day readmission rateParticipants will be followed for the duration of each hospital stay and 30 days post-hospitalization, for an expected average of 37 days.

Number of hospitalizations that occur within 30 days after discharge from an initial index hospitalization (convert to percentage of 30-day readmissions).

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Fresenius

🇺🇸

Franklin, Tennessee, United States

© Copyright 2025. All Rights Reserved by MedPath